Actuate Therapeutics ACTU
NASDAQ ACTU
$0.30 -0.02 (-5.32%)
At close: Nov 10, 2026 · 4:00 PM EST

Actuate Therapeutics (ACTU) EBT (2023 - 2026)

Updated

Actuate Therapeutics' EBT was -$4.87 million in Q2 2026, compared with -$5.95 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) EBT (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Actuate Therapeutics' EBT was -$20.78 million through Jun 30, 2026; for FY2025, it came in at -$22.23 million.

  • In earlier years, EBT was -$24.96 million in FY2024 and -$24.66 million in FY2023.
  • Quarterly EBT has moved between -$7.76 million (Q1 2024) and -$4.55 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 34.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 4.83 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 2.80 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.69 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.06 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 3.39 Bn
10 Actuate Therapeutics 7.56 Mn -35.08 Mn - -4.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.87 Mn
Dec 31, 2025 -4.55 Mn
Sep 30, 2025 -5.41 Mn
Jun 30, 2025 -5.95 Mn
Mar 31, 2025 -6.32 Mn
Dec 31, 2024 -6.45 Mn
Sep 30, 2024 -5.32 Mn
Jun 30, 2024 -5.43 Mn
Mar 31, 2024 -7.76 Mn
Dec 31, 2023 -7.56 Mn
Sep 30, 2023 -6.35 Mn
Jun 30, 2023 -5.59 Mn
API Access

Actuate Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ACTU&period=max&api_key=YOUR_API_KEY